Symbol="CHRS"
AssetType="Common Stock"
Name="Coherus BioSciences Inc"
Description="Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California."
CIK="1512762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="444002000"
EBITDA="-225456000"
PERatio="None"
PEGRatio="0"
BookValue="-1.85"
DividendPerShare="0"
DividendYield="0"
EPS="-3.33"
RevenuePerShareTTM="2.255"
ProfitMargin="-1.452"
OperatingMarginTTM="-1.261"
ReturnOnAssetsTTM="-0.282"
ReturnOnEquityTTM="-16.57"
RevenueTTM="181928000"
GrossProfitTTM="-58399000"
DilutedEPSTTM="-3.33"
QuarterlyEarningsGrowthYOY="-0.755"
QuarterlyRevenueGrowthYOY="-0.024"
AnalystTargetPrice="12.75"
TrailingPE="-"
ForwardPE="32.89"
PriceToSalesRatioTTM="2.354"
PriceToBookRatio="73.19"
EVToRevenue="3.202"
EVToEBITDA="-3.109"
Beta="0.902"
num_52WeekHigh="12.03"
num_52WeekLow="3.6"
num_50DayMovingAverage="4.477"
num_200DayMovingAverage="6.43"
SharesOutstanding="94468000"
DividendDate="None"
ExDividendDate="None"
symbol="CHRS"
open="4.57"
high="4.72"
low="4.51"
price="4.70"
volume="1134872.00"
latest_trading_day="2023-08-25"
previous_close="4.57"
change="0.13"
change_percent="2.8446%"
aroon_positive_momentum_days="18"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="2835903"
Change_recent_avg="-0.03"
Delta_recent_avg="0.38"
Variance_recent_avg="0.19"
Change_ratio_recent_avg="-0.75"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_negative_thumbnail_id_2="504"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0101.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="994"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_positive_thumbnail_id_2="683"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
